Promacta® Pregnancy Registry
PROMACTA (Thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenia (ITP))
The PROMACTA® Pregnancy Registry is an observational pregnancy exposure study conducted in the United States to detect and record adverse events in a mother exposed to Promacta® during her pregnancy, and any adverse events observed in the neonate/infant through the first year of life.
Subjects should be registered as early in pregnancy as possible, and before any prenatal testing for congenital anomalies. Ongoing pregnancies may also be registered where exposure to Promacta® has already occurred.
Patients can be registered by calling GlaxoSmithKline directly at 1-888-483-5249 (toll-free).
GlaxoSmithKline's Promacta® Pregnancy Registry is managed at:
PROMACTA® Pregnancy Registry
The Promacta® Pregnancy Registry requires that the patient must provide informed consent for participation in this registry. Measures are in place to protect patient confidentiality.